The protein encoded by this gene is similar to the protein transgelin, which is one of the earliest markers of differentiated smooth muscle. The specific function of this protein has not yet been determined, although it is thought to be a tumor suppressor. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2013].
Liang, Jin, Wang, Meng, Tan, Huang, Fan: "Transgelin 2 is required for embryo implantation by promoting actin polymerization." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Issue 4, pp. 5667-5675, (2019) (PubMed).
Stadler, Hjelmare, Neumann, Jonasson, Pepperkok, Uhlén, Lundberg: "Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy." in: Journal of proteomics, Vol. 75, Issue 7, pp. 2236-51, (2012) (PubMed).
Yoshino, Chiyomaru, Enokida, Kawakami, Tatarano, Nishiyama, Nohata, Seki, Nakagawa: "The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer." in: British journal of cancer, Vol. 104, Issue 5, pp. 808-18, (2011) (PubMed).
Nohata, Sone, Hanazawa, Fuse, Kikkawa, Yoshino, Chiyomaru, Kawakami, Enokida, Nakagawa, Shozu, Okamoto, Seki: "miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma." in: Oncotarget, Vol. 2, Issue 1-2, pp. 29-42, (2011) (PubMed).